Repurposing rosiglitazone, a PPAR-γ agonist and oral...

  • Main
  • 2018 / 4
  • Repurposing rosiglitazone, a PPAR-γ agonist and oral...
Journal of Controlled Release 2018 / 4

Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH

Rashid, Jahidur, Alobaida, Ahmad, Al-Hilal, Taslim A., Hammouda, Samia, McMurtry, Ivan F., Nozik-Grayck, Eva, Stenmark, Kurt R., Ahsan, Fakhrul
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Controlled Release
DOI:
10.1016/j.jconrel.2018.04.049
Date:
April, 2018
File:
PDF, 1.55 MB
english, 2018
Conversion to is in progress
Conversion to is failed